Artus Therapeutics
PrivateLast Round
Grant
Jul 1, 2021
Total Funding Raised
$501,189
Company Overview
Artus Therapeutics is a biotechnology company that develops small-molecule therapeutics for inflammatory and metabolic diseases by targeting gut barrier dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artus Therapeutics Comparables
Compare Artus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncostellae | 84% | |
| Orphagen Pharmaceuticals | 80% | |
| Piton Therapeutics | 79% | |
Artus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2021 | ||||
| Seed | Aug 1, 2019 |
Artus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors grew 60% MoM, reaching 1.6K.
- Jul 1, 2021
$501K grant awarded by the National Institutes of Health.
Artus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artus Therapeutics's valuation, stock price, and market status.